Ranbaxy launches arthritis drug Infimab in India
New Delhi, Dec 1 (PTI) Ranbaxy Laboratories today launched the first biosimilar version of Johnson and Johnson's Remicade, a drug used for treating various conditions
- Home
- About Oana
-
Oana Activities
- General Assembly
-
Executive Board Meetings
- 52th Executive Board Meeting
- 51th Executive Board Meeting
- 50th Executive Board Meeting
- 49th OANA Executive Board Meeting
- 48th OANA Executive Board Meeting
- 47th OANA Executive Board Meeting
- 46th OANA Executive Board Meeting
- 45th OANA Executive Board Meeting
- 44thOANA Executive Board Meeting
- 43rd OANA Executive Board Meeting
- 42nd OANA Executive Board Meeting
- 41st OANA Executive Board Meeting
- 40th OANA Executive Board Meeting
- 39th OANA Executive Board meeting
- The 38th OANA Executive Board meeting
- The 37th OANA Executive Board Meeting
- 34th Executive Board Meeting Minutes
- The 31st OANA Executive Board Meeting
- The 30th OANA Executive Board Meeting
- Technical Meeting
- OANA Members
-
OANA Declaration
- OANA & FANA JOINT PRESS STATEMENT December 2023
- Declaration of Istanbul 2023
- Tehran Declaration 2022
- The Seoul 2019 Declaration
- OANA Seoul 2015 Declaration
- The OANA 50th Anniversary Ethical Guidelines Declaration
- The Istanbul Declaration
- The Seoul Declaration
- The Jakarta Declaration
- The Kuala Lumpur Declaration
- The Kuwait Declaration
- OANA Award
- OANA Ethics Code
- Terms of Use
- Contact
- Login
X